14r,15s-epetre

14r,15s-epetre is a lipid of Fatty Acyls (FA) class. 14r,15s-epetre is associated with abnormalities such as Heart failure, Chronic Obstructive Airway Disease, Pneumonia and Fatty Liver. The involved functions are known as chromophore, Stereochemistry, Cell Respiration, cell transformation and oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen. 14r,15s-epetre often locates in Lambda, Cardiovascular system, Blood, Body tissue and Protoplasm. The associated genes with 14r,15s-epetre are CCL2 gene, Cytokine Gene, CYP2C18 gene, CYP2C19 gene and TEK gene. The related lipids are Palmitates.

Cross Reference

Introduction

To understand associated biological information of 14r,15s-epetre, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 14r,15s-epetre?

14r,15s-epetre is suspected in Heart failure, Chronic Obstructive Airway Disease, Pneumonia, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 14r,15s-epetre

MeSH term MeSH ID Detail
Coronary Occlusion D054059 4 associated lipids
Lung Injury D055370 14 associated lipids
Pre-Eclampsia D011225 16 associated lipids
Hypertrophy D006984 16 associated lipids
Hyperemia D006940 25 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Brain Ischemia D002545 89 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Insulin Resistance D007333 99 associated lipids
Hypertension D006973 115 associated lipids
Per page 10 20 | Total 11

PubChem Associated disorders and diseases

What pathways are associated with 14r,15s-epetre

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 14r,15s-epetre?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 14r,15s-epetre?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 14r,15s-epetre?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 14r,15s-epetre?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 14r,15s-epetre?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 14r,15s-epetre

Download all related citations
Per page 10 20 50 100 | Total 232
Authors Title Published Journal PubMed Link
Chadderdon SM et al. Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates. 2012 Am. J. Physiol. Endocrinol. Metab. pmid:22739105
Gupta NC et al. Soluble epoxide hydrolase: sex differences and role in endothelial cell survival. 2012 Arterioscler. Thromb. Vasc. Biol. pmid:22723436
Decker M et al. EH3 (ABHD9): the first member of a new epoxide hydrolase family with high activity for fatty acid epoxides. 2012 J. Lipid Res. pmid:22798687
Theken KN et al. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. 2012 Atherosclerosis pmid:22503544
Zhang D et al. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. 2012 Circ. Res. pmid:22354938
Herse F et al. Cytochrome P450 subfamily 2J polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia. 2012 Circulation pmid:23155181
Li R et al. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice. 2012 Prostaglandins Other Lipid Mediat. pmid:23041291
Ward NC et al. Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controls. 2011 Clin. Sci. pmid:21689071
Pavlov TS et al. Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC). 2011 Am. J. Physiol. Renal Physiol. pmid:21697242
Mitra R et al. CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET). 2011 J. Biol. Chem. pmid:21402692
Schebb NH et al. Development of an online SPE-LC-MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors. 2011 Anal Bioanal Chem pmid:21479549
Chen Y et al. 20-Iodo-14,15-epoxyeicosa-8(Z)-enoyl-3-azidophenylsulfonamide: photoaffinity labeling of a 14,15-epoxyeicosatrienoic acid receptor. 2011 Biochemistry pmid:21469660
Sridar C et al. Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6. 2011 Drug Metab. Dispos. pmid:21289075
Skepner JE et al. Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes. 2011 Prostaglandins Other Lipid Mediat. pmid:21040800
Shao J et al. P-450-dependent epoxygenase pathway of arachidonic acid is involved in myeloma-induced angiogenesis of endothelial cells. 2011 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:22038346
Zhu P et al. Development of a semi-automated LC/MS/MS method for the simultaneous quantitation of 14,15-epoxyeicosatrienoic acid, 14,15-dihydroxyeicosatrienoic acid, leukotoxin and leukotoxin diol in human plasma as biomarkers of soluble epoxide hydrolase activity in vivo. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21798825
Gauthier KM et al. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles. 2011 Am. J. Physiol. Renal Physiol. pmid:21753077
Farr H and David T Models of neurovascular coupling via potassium and EET signalling. 2011 J. Theor. Biol. pmid:21781976
Senouvo FY et al. Improved bioavailability of epoxyeicosatrienoic acids reduces TP-receptor agonist-induced tension in human bronchi. 2011 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:21821730
Sarkar P et al. Differential effect of amyloid β on the cytochrome P450 epoxygenase activity in rat brain. 2011 Neuroscience pmid:21843605